The importance of risk communication and documentation for patients with cutaneous adverse drug reactions

We read with interest Teo et al.'s recently published article examining cutaneous adverse drug reactions (cADR) referred to an inpatient liaison dermatology service.¹ The authors assessed the number and types of cADR encountered and subsequent documentation.¹ The diagnosis and management of cADR has been recognised by NICE Guidelines on Drug Allergy as a high-priority area for quality improvement.² We commend Teo and colleagues¹ for examining an essential, yet often overlooked, component of health service quality. We would like to further highlight the importance of risk communication, documentation and patient-centred care, aspects that are imperative for severe cADR.

This article is protected by copyright. All rights reserved.

http://ift.tt/2sIF9bg